Drug treatment of dyslipoproteinemia
- 1 January 1994
- journal article
- Published by Elsevier in Medical Clinics of North America
- Vol. 78 (1) , 225-245
- https://doi.org/10.1016/s0025-7125(16)30184-5
Abstract
No abstract availableKeywords
This publication has 81 references indexed in Scilit:
- Treatment of familial hypercholesterolaemia. United Kingdom lipid clinics study of pravastatin and cholestyramine.BMJ, 1992
- Double-blind comparison of bezafibrate versus placebo in male volunteers with hyperlipoproteinemiaAtherosclerosis, 1992
- Long-term safety and efficacy profile of simvastatinThe American Journal of Cardiology, 1991
- Expanded clinical evaluation of lovastatin (EXCEL) study results: III. Efficacy in modifying lipoproteins and implications for managing patients with moderate hypercholesterolemiaThe American Journal of Medicine, 1991
- Expanded Clinical Evaluation of Lovastatin (EXCEL) Study ResultsArchives of internal medicine (1960), 1991
- Lovastatin versus Bezafibrate: Efficacy, Tolerability, and Effect on Urinary MevalonateCardiology, 1990
- Effect of a modified, well-tolerated niacin regimen on serum total cholesterol, high density lipoprotein cholesterol and the cholesterol to high density lipoprotein ratioThe American Journal of Cardiology, 1989
- ProbucolDrugs, 1989
- High density lipoprotein cholesterol, total cholesterol screening, and myocardial infarction. The Framingham Study.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1988
- A Receptor-Mediated Pathway for Cholesterol HomeostasisScience, 1986